R 252045Z SEP 24 MARADMIN 440/24 MSGID/GENADMIN/CMC WASHINGTON DC// SUBJ/2024-2025 INFLUENZA VACCINE GUIDANCE FOR ACTIVE AND RESERVE  COMPONENTS// REF/A/DOC/USD P&R WASHINGTON DC/23JUL19// REF/B/DOC/BUMED WASHINGTON DC/07OCT13// REF/C/DOC/DHA WASHINGTON DC/21AUG20// REF/D/DOC/CNO WASHINGTON DC/22NOV16// REF/E/DOC/32 CFR PART 199.21/01DEC16// REF/F/DOC/CDC/MMWR RECOMMENDATIONS AND REPORTS NO. 5/29AUG2024// NARR/REF A IS DODINST 6205.02, DOD IMMUNIZATION PROGRAM. REF B  IS BUMEDINST 6230.15B, IMMUNIZATIONS AND CHEMOPROPHYLAXIS FOR THE PREVENTION OF INFECTIOUS DISEASES. REF C IS DEFENSE HEALTH AGENCY (DHA) PROCEDURAL INSTRUCTION 6025.34, GUIDANCE FOR THE DOD  INFLUENZA VACCINATION PROGRAM. REF D IS OPNAVINST 3710.7V, NAVAL AIR TRAINING AND OPERATING PROCEDURES STANDARDIZATION GENERAL  FLIGHT AND OPERATING INSTRUCTIONS. REF E IS THE CIVILIAN HEALTH  AND MEDICAL PROGRAM OF THE UNIFORMED SERVICES (CHAMPUS)/TRICARE:  TRICARE PHARMACY BENEFITS PROGRAM. REF F IS THE CENTERS FOR  DISEASE CONTROL AND PREVENTION (CDC) RECOMMENDATIONS FOR 2024-2025 INFLUENZA SEASON.// POC/DRISCOLL, SEAN/CDR/HQMC/HS/DIRECTOR OF PUBLIC HEALTH/TEL:  703-604-4602/ EMAIL: [email protected]// POC/BALISI, FRANCISPAUL/HM1/HQMC/HS/MRRS COORDINATOR/TEL: 703-604-4602/ EMAIL: [email protected]// GENTEXT/REMARKS/1.  Purpose.  Provide guidance to Marine Corps  active and reserve components to implement the 2024-2025 Northern and Southern Hemisphere Influenza Vaccination Program. 2.  Background.  Seasonal Influenza is a highly contagious disease that has the potential to significantly impact force health and  mission readiness.  A timely comprehensive vaccination program must  be enforced by Marine Corps leadership in order to mitigate risk to  force and risk to mission.  Maximum vaccination of the force reduces transmission of disease and reduces severity of disease in  personnel who become infected.  3.  Execution 3.a.  Per references (a), (b), and (c), all Marine Corps active and  reserve component personnel shall receive the 2024-2025 Seasonal  Influenza vaccine(s) unless medically or administratively exempt.   The Marine Corps active component shall ensure 100 percent of  personnel are compliant with Department of Defense (DoD) policy  (vaccinated or approved medical or administrative exemption) no later than 15 December 2024.  The Marine Corps reserve component  shall vaccinate at least 90 percent of required personnel no later than the DoD goal of 15 January 2025. 3.b.  Per enclosure (3) of reference (c), Marine Corps personnel shall  receive the seasonal Northern Hemisphere (NH) Influenza vaccine if they will be assigned, permanently or temporarily, more than 14 days in the NH Influenza zone between 1 October 2024 and 30 March 2025. Marine Corps personnel shall receive the seasonal Southern Hemisphere (SH) Influenza vaccine if they will be assigned more than 14 days in the SH Influenza zone between 1 April 2025 and 30  September 2025 (see reference (c), appendix (5), for a list of applicable countries).  If personnel require vaccination with both hemisphere vaccines, administration should be separated by a minimum of 30 days. 3.c.  Operational forces and training commands are prioritized for  receipt of Influenza vaccine by the Department of the Navy.   Marine Corps component commanders and surgeons shall coordinate  with supporting Military Treatment Facilities (MTFs) to ensure  operational forces and training commands receive priority  administration from Influenza vaccine shipments.  Commanders should  prioritize vaccination of deploying forces, recruits and instructors  at recruit depots, and healthcare providers assigned to Marine Corps units. 3.d.  Commanders should advise Marine Corps civilian employees that  the Influenza vaccine is also available to them at retail  pharmacies, without cost or copay, as a benefit of the Federal  Employee Health Benefits program.  See paragraph 6.a for additional  information. 3.e.  Marine Corps active and reserve component commands shall  monitor Influenza vaccination compliance via the Medical Readiness  Reporting System (MRRS), and coordinate with supporting MTFs to  ensure seasonal Influenza vaccination compliance no later than the  deadlines in paragraph 3.a. 3.f.  Marine Corps components will document administration of  Influenza vaccine for all personnel in the Electronic Health  Record (Military Health System GENESIS) preferentially, but may  document vaccination directly in MRRS if the units do not have  ready access to the Electronic Health Record.  Vaccination shall  be documented within one (1) business day of administration to  ensure timely and accurate daily monitoring of Force compliance  with this MARADMIN.  3.g.  Personnel who receive Influenza vaccination from non-military  facilities (e.g., civilian pharmacies) shall provide verification  and details to their supporting MTF or command MRRS representative  no later than 1600 on the next regular duty day (see paragraph 6.a). 3.h.  If a command does not have authorized personnel with access  to MRRS, contact the local MRRS security officer or the  Headquarters Marine Corps Health Services MRRS POC listed in this  message for further assistance. 3.i.  Medical exemptions will be entered in MRRS only when an  individual has a valid exemption for the Influenza vaccine, as  determined by a licensed healthcare provider.  See references (b) and (c) for details regarding exemptions and required evaluation of those reporting a history of allergic reaction to the Influenza  vaccine. 3.j.  Administrative exemptions are a non-medical command  determination, and will be entered in MRRS in accordance with  reference (b).  Units are advised to refrain from temporary  exemptions due to TAD status in order to avoid erroneous exemptions and ensure compliance with reference (a).  4.  Vaccine Handling and Administration 4.a.  Commanders shall ensure that all medical personnel assigned  to Marine Corps units who handle and/or administer Influenza vaccine receive appropriate annual training and that competencies are  documented.  Commanders shall also establish procedures for proper  handling and storage of Influenza immunization stock in accordance with reference (c) and regional policy and practices of the supporting MTF. 4.b.  Only appropriately trained and qualified personnel, working  under signed orders of an appropriately privileged healthcare  provider will administer the Influenza vaccine. 4.c.  All personnel handling and/or administering Influenza vaccine  shall receive training in cold-chain management and have a signed  competency form verifying competency in all aspects of the Influenza vaccine products being utilized.  Training can be accessed via  Joint Knowledge Online (DHA-US070), and additional comprehensive  resources are available at www.health.mil/vaccines. 4.d.  Influenza vaccines shall be stored and transported, at all  times, with appropriate temperature monitoring. 4.e.  Any time that a temperature compromise is known or suspected,  immediately place that vaccine in a proper storage container at the  proper temperature, and clearly label “DO NOT USE”.  Do not discard  the vaccine unless directed by Defense Logistics Agency-Troop  Support Medical (DLA-TSM).  Notify the supporting MTF, Naval Medical Readiness Logistics Command (NMRLC) vaccine service representative  at [email protected], and the  appropriate DHA Immunization Healthcare Specialist. Complete a DHA Form 177, Potentially Compromised Temperature Sensitive Medical  Provider Worksheet.  DLA-TSM will advise on disposition of the  vaccine. 4.f.  Commands with excess Influenza vaccine that will not be used  prior to expiration shall notify their supporting MTF, NMRLC vaccine service representative, and DHA Immunization Healthcare Specialist, who may direct redistribution. 4.g.  Prior to vaccination, all personnel being vaccinated shall be  screened by medical personnel using DHA Form 116, and shall be  provided the current Vaccine Information Statement (VIS) for the  product being administered. 4.h.  Aircrew will require a period of grounding specific to the  product being administered, per reference (d). 5.  Adverse Reactions.  Local swelling, injection site soreness,  and headache are common Influenza vaccine side effects that resolve  quickly.  These symptoms, along with fever, fatigue, and muscle  aches may occur within 6-12 hours of vaccination, and may persist  for 1-2 days.  More severe allergic reactions, while rare, shall be  evaluated by medical personnel and reported through the Vaccine  Adverse Event Reporting System (VAERS) at:  https:(slash)(slash)vaers.hhs.gov/reportevent.html. 6.  Additional Information 6.a.  Per reference (e), TRICARE Prime beneficiaries, including all  active duty service members, may utilize TRICARE-authorized  pharmacies to receive the seasonal Influenza vaccine at no cost.   Participating pharmacies may be found at:  https:(slash)(slash)militaryrx.express-scripts.com(slash) find-pharmacy.  Personnel utilizing this option shall provide their supporting MTF and/or MRRS representative documentation of the manufacturer, lot number, amount and location given (right arm, left arm), and date of administration.  Command medical personnel and/or MRRS representatives must ensure that documentation of Influenza vaccine administration is coded to accurately reflect the type of  vaccine given. 6.b.  The DHA’s Influenza vaccine resource center can be found  at www.health.mil/vaccines, and contains guidance documents and  templates to include standing orders, vaccine product guides and  VISs, and cold chain management tools. 6.c.  The Defense Health Agency-Immunization Healthcare Division  (DHA-IHD) Immunization Healthcare Support Center can be reached  at: 1-877-GET-VACC (1-877-438-8222); or via email  at:  [email protected].  The Support Center can provide clinical  consultation, to include assistance with questions regarding  vaccine screening and potential vaccine-related adverse events. 7.  This MARADMIN is applicable to the Marine Corps Total Force. 8.  This MARADMIN is cancelled 1 August 2025. 9.  Release authorized by Lieutenant General Paul J. Rock, Jr.,  Director, Marine Corps Staff.//